medigraphic.com
SPANISH

Revista Médica del Instituto Mexicano del Seguro Social

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 2

Next >>

Rev Med Inst Mex Seguro Soc 2012; 50 (2)

The clinical practice guideline for the diagnosis and treatment of atrial fibrillation. Medical reflections from the daily practice

Martínez-Flores JE
Full text How to cite this article

Language: Spanish
References: 8
Page: 117-122
PDF size: 313.23 Kb.


Key words:

atrial fibrilation, practice guidelines.

ABSTRACT

Atrial fibrillation (AF) represents a global public health problem. The implementation of a clinical practice guideline is essential to standardize the diagnosis, treatment and prognosis of this rhythm disturbance. However, due to the wide clinical spectrum which is associated with AF, it makes difficult to standardize the recommendations and cause that are not always appropriate interpretations of the same setting, so there will be some clinical reflections of the recommendations in the clinical practice guidelines published in this journal, to assist the medical not specialist to put them in everyday clinical setting.


REFERENCES

  1. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guías de práctica clínica para el manejo de la fibrilación auricular. 2ª edición corregida. 8 de abril de 2011. Grupo de Trabajo para el Manejo de la Fibrilación Auricular de la Sociedad Europea de Cardiología (ESC). Rev Esp Cardiol 2010;63:1483.e1-e83.

  2. Fuster V, Rydén L E, Cannom D S, Crijns H J, Curtis A B, Ellenbogen K A, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2006;48:e149-e246.

  3. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes M, et al. ACCF/AHA/HRS FOCUSED UPDATE. 2011 ACCF/AHA/HRS Focused update on the management of patients with atrial fibrillation (updating the 2006 guideline). Heart Rhythm 2011;8:157-176.

  4. Wann LS, Curtis AB, Ellenbogen KA, Estes M, Ezekowitz MD, Jackman WM, et al. 2011 ACCF/AHA/HRS Focused update on the management of patients with atrial fibrillation (update on dabigatran). Heart Rhythm 2011;8:e1-e8.

  5. Uchino K, Hernández AV. Dabigatran association with higher risk of acute coronary events. Arch Intern Med 2012; E1-E6.

  6. Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, et al.; EURIDIS and ADONIS Investigators. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007;357(10):987-999.

  7. Honloser SH, Crijns H, Eickles MV, Gaudin C, Page RL, Torp-Pedersen C, et al; ATHENA Investigators. Effects of dronedarone on cardiovascular event in atrial fibrillation. N Engl J Med 2009;360;668-678.

  8. Connolly SJ, Camm AJ, Halperin JL. Dronedarone in highrisk permanent atrial fibrillation. N Engl J Med 2011;365: 2268-2276.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Inst Mex Seguro Soc. 2012;50